PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Thorax. Author manuscript; available in PMC Jan 1, 2010.
Published in final edited form as:
Published online Nov 10, 2008. doi:  10.1136/thx.2008.101543
PMCID: PMC2630423
NIHMSID: NIHMS87425
Effect of breastfeeding duration on lung function at age 10 years: a prospective birth cohort study
I U Ogbuanu,1 W Karmaus,1 S H Arshad,2 R J Kurukulaaratchy,2 and S Ewart3
1 Department of Epidemiology and Biostatistics, Norman J Arnold School of Public Health, University of South Carolina, USA
2 David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, and University of Southampton, Southampton, UK
3 College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA
Correspondence to: Dr I U Ogbuanu, Department of Epidemiology and Biostatistics, Norman J Arnold School of Public Health, University of South Carolina, 800 Sumter Street, Columbia, SC 29208, USA; dr_iyke/at/yahoo.com
Introduction
The protective effects of breastfeeding on early life respiratory infections are established, but there have been conflicting reports on protection from asthma in late childhood. The association of breastfeeding duration and lung function was assessed in 10-year-old children.
Methods
In the Isle of Wight birth cohort (n = 1456), breastfeeding practices and duration were prospectively assessed at birth and at subsequent follow-up visits (1 and 2 years). Breastfeeding duration was categorised as “not breastfed” (n = 196); “<2 months” (n = 243); “2 to <4 months” (n = 142) and “≥4 months” (n = 374). Lung function was measured at age 10 years (n = 1033): forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF). Maternal history of asthma and allergy was assessed at birth. The effect of breastfeeding on lung function was analysed using general linear models, adjusting for birth weight, sex, current height and weight, family social status cluster and maternal education.
Results
Compared with those who were not breastfed, FVC was increased by 54.0 (SE 21.1) ml (p = 0.001), FEV1 by 39.5 (20.1) ml(p = 0.05) and PEF by 180.8 (66.1) ml/s (p = 0.006) in children who were breastfed for at least 4 months. In models for FEV1 and PEF that adjusted for FVC, the effect of breastfeeding was retained only for PEF (p = 0.04).
Conclusions
Breastfeeding for at least 4 months enhances lung volume in children. The effect on airflow appears to be mediated by lung volume changes. Future studies need to elucidate the mechanisms that drive this phenomenon.
Breast feeding is beneficial for the health of infants and children. Analysis of human breast milk has yielded several immunoactive factors, and these have been proposed as responsible for the beneficial effects observed.1-9 Specifically, several studies have reported the protective effects of breastfeeding on lower respiratory infections, which were associated with exclusivity and duration of breastfeeding.10-15 However, the evidence with regard to asthma risk has been conflicting, especially after controlling for breastfeeding duration and for maternal allergy and asthma.16-21
A recent study (Tucson Children Respiratory Survey) showed that breastfeeding for 4 months or longer favourably influenced lung growth in the total cohort, but air flow obstruction was seen in the presence of maternal asthma.22 The purpose of the current analysis was to explore this relationship and to evaluate the effect of breastfeeding on pulmonary function in later childhood.
Pulmonary function (lung volume and flow rate) could be altered in several physiological and pathological states. Lung volume measurements reflect the stiffness or elasticity of the lungs and rib cage as well as the strength of respiratory muscles. Flow rate measurements reflect the degree of narrowing or obstruction of the airways. Flow rate measurements are abnormal in obstructive disorders, such as chronic obstructive pulmonary disease and asthma. In this study, we used lung function as a measure of susceptibility to asthma.23
Study population
Between January 1989 and February 1990, children born on the Isle of Wight, UK, were recruited to participate in a longitudinal study (n = 1456). The local research ethics committee approved the study and informed written parental consent was obtained for all participants at recruitment and subsequently at each follow-up. This whole population birth cohort was largely Caucasian (99%) and living in a semi-rural environment with no heavy industry. The Isle of Wight birth cohort has been described in detail elsewhere.24 25
Briefly, at birth, birth weight was measured and data from birth records and extensive questionnaires were collected, including information on asthma and family history of allergy, as well as maternal smoking habits. Breastfeeding practices and duration were prospectively assessed at birth and at subsequent follow-up visits (1 and 2 years). At ages 1, 2, 4 and 10 years, the original questionnaire based information was updated, a study physician performed physical examinations on the children and symptoms of asthma and allergic diseases were recorded. Skin prick tests to common food and aeroallergens were administered at the 4 and 10 year follow-up visits,26 and at age 10 years lung function tests were performed on all consenting children (n = 1033). To assess whether our analytic sample (children with pulmonary function test data available) was representative of the total cohort available at age 10 years, we compared the characteristics of these two subsets (table 1)
Table 1
Table 1
Baseline characteristics for children with lung function data at age 10 years compared with the total cohort available for the 10-year follow-up
Lung function measurements
Lung function testing was performed using Koko spirometry software (PDS Instrumentation, Louisville, USA), according to American Thoracic Society guidelines.27 To perform spirometry, children were required to be free from respiratory infection for 14 days, and not be taking oral steroids; they must have abstained from any β agonist medication for 6 h and caffeine intake for at least 4 h. For consistency, the highest of three FEV1 measurements that were within 5% of each other was recorded.
Variable definitions
Following the classification of the Tucson Children's Respiratory Study,22 breastfeeding duration was categorised into four groups: “not breastfed” (n = 196; referent group); “breastfed for less than 2 months” (n = 243); “breastfed for more than 2 but less than 4 months” (n = 142) and “breastfed for at least 4 months” (n = 374).
Lung function assessment at age 10 years included forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF).
Covariates
Birth weight (continuous variable), sex (dichotomous variable), current height and weight (continuous variables), family social status cluster and maternal education were adjusted for in all explanatory models. Maternal history of asthma and allergy was assessed by questionnaire at birth as present or absent. Mothers were regarded as allergic if they reported one or more clinical allergic diseases.
Information on tobacco smoking by mothers (during pregnancy and later), fathers or any other individual inside the home was recorded at recruitment and updated at each follow-up. Exposures to environmental tobacco smoke (ETS) in the household and maternal smoking during pregnancy were combined and classified into three groups. When mothers did not smoke during pregnancy and there was no exposure to household ETS in children up to the age of 10 years, children were categorised as “ETS-0”. When mothers did not smoke during pregnancy but household members smoked within the home at some point up to the child's age of 10 years, the exposure status was categorised as “ETS-1”. When mothers smoked during pregnancy and the children were also exposed to household ETS at some point up to the age of 10 years, the exposure was categorised as “ETS-2”. None of the children had mothers who smoked during pregnancy with no exposure to household tobacco smoke after birth.28
“Family social status cluster” is a composite variable that accounts for “socioeconomic status” broadly defined. The Isle of Wight population has been characterised as semi-rural, with most families (63%) residing in “owner occupied” homes that have been owned by their families for decades. In order to correctly classify them, we chose to cluster family social status using the following three variables: (a) the British socioeconomic classes (1−6) derived from parental occupation reported at birth; (b) the number of children in the index child's bedroom (collected at age 4 years); and (c) family income at age 10 years. This composite variable captures the family social class across the entire study period.
The British Registrar General's social classification grouping places professional occupations in group 1 and unskilled manual occupations in group 5, with two subgroups within group 3 (3.1 = non-manual and 3.2 = manual). Family income at age 10 years was recorded under six categories: class 1 = less than £12 000; 2 = £12 000 to £17 999; 3 = £18 000 to £29 999, 4 = £30 000 to £41 999, 5 = £42 000 and greater. The number of children who shared one bedroom ranged from 1 to 3. A cluster analysis of these three variables yielded six groups, one clearly “highest” and one clearly “lowest” status, and four “middle” clusters representing a diversity of middle class living conditions.
In addition, we also investigated the effect of the number of years of formal education completed by the mother, using the number of years of compulsory education as a metric. The maternal education variable was ascertained at the 10 year follow-up and classified into three groups: “less than compulsory” (<16 years of formal education), “compulsory” (16−18 years) and “more than compulsory” (≥19 years).
Statistical analyses
FVC, FEV1, FEV1/FVC ratio and PEF were approximately normally distributed at age 10 years. General linear models were used to assess mean differences in lung function (dependent variable) among the four levels of breastfeeding duration, as defined above, using those who were not breastfed as the referent group. Changes in lung function were presented as millilitres (SE). Separate models were run for each lung function variable. A backward selection approach was utilised to retain confounders in the final model if they changed the effect of breastfeeding categories by 10% or more (table 2).
Table 2
Table 2
Adjusted linear regression models for lung function at age 10 years and breastfeeding duration
Following our hypothesis that the effect of breast feeding would differ across levels of maternal history of asthma and allergy, we assessed the interaction between breastfeeding duration and maternal asthma and allergy.
To test whether the sample we analysed differed from the total sample available at the 10 year follow-up, we compared these two subgroups using cross tabulation. There were no substantial differences between the total cohort at age 10 years and the sample that had lung function data available across the breastfeeding duration categories (primary exposure) and other variables of interest (table 1).
Compared with children who were not breastfed, those who were breastfed for at least 4 months had FVC values that were, on average, 54 ml larger than those who were not breastfed, after adjusting for current height and weight, birth weight, gender, family social status cluster and maternal education (54 (SE 21.1) ml; p = 0.01) (table 2, model 1). Similarly, children who were breastfed for 4 months or longer had significantly higher PEF (180.8 (66.1) ml/s; p = 0.006). FEV1 was marginally significant (39.5 (20.1); p = 0.05) while FEV1/FVC was not significantly associated with breastfeeding duration in this cohort of children. In all models, breastfeeding for less than 4 months did not show significant beneficial effects on lung function (table 2).
The lack of statistical significance seen with the FEV1/FVC ratio may suggest that adjustment for vital capacity diminishes the effect of breastfeeding on FEV1. In this regard, inclusion of FVC as a covariate in the explanatory model for FEV1 also led to a significant reduction of the effect on FEV1 from 39.5 ml to −1.6 ml (table 2, model 2).
To further investigate whether vital capacity was the major driver of the changes found for PEF, we re-ran the PEF explanatory model also controlling for FVC (table 2, model 2). Comparing model 1 with model 2 showed that controlling for FVC reduced the effect of breastfeeding duration on PEF from 180.8 to 131.7 ml/s. However, even after controlling for FVC, breastfeeding duration maintained its statistically significant effect on PEF, in contrast with the effect of controlling for FVC on the association of breastfeeding with FEV1.
In addition, to test whether the association of breastfeeding and lung function parameters varied with history of maternal asthma and maternal atopy, we included two interaction terms in the models. These did not gain statistical significance, showing that in this cohort of children, the effect of breastfeeding duration on lung function measurements was not modified by maternal history of asthma or allergy.
This study assessed the relationship between duration of breastfeeding and lung function in a well characterised whole population birth cohort at the Isle of Wight, UK. Children who were breastfed for at least 4 months were found to have a significantly better lung function profile at age 10 years compared with those who were not breastfed. Although there was a trend of higher FEV1 and higher PEF with increasing duration of breastfeeding, a statistically significant increase in lung volume was not seen in children who were breastfed for shorter durations (less than 4 months). Our data also showed no evidence of effect modification by maternal history of asthma and allergy.
The likelihood that our results are caused by selection bias is minimised by the fact that all births were eligible, and 1456 of 1536 eligible children (94.8%) agreed to participate. In addition, 94.1% (1370/1456) of the birth cohort participated at the 10 year follow-up. We compared our analytic sample with the total cohort available at age 10 years for evidence of selection bias but found no such evidence (table 1). The prospective nature of the data collection (breastfeeding information was ascertained at ages 1 and 2 years) and the fact that the primary outcome variable was assessed instrumentally at the clinic at the 10 year visit, combine to reduce information bias (reporting bias). These factors increase both the internal and external validity of this study.
When testing for interaction, we used maternal history of asthma and allergy from standard questionnaires. We did not find any effect modification of breastfeeding by maternal history of asthma or allergy. This finding is in contrast with that of Guilbert and colleagues.22 Although there was no information on the test for interaction effect in their report, Guilbert et al stratified their sample by maternal asthma and atopy and found a differential effect of the relation of breastfeeding to lung function depending on maternal asthmatic background. Of note, however, we classified maternal asthma and allergy using historical questionnaire information, because of the absence of clinical testing in the mothers. While this approach may not completely capture the effect of maternal asthma and atopy, the internal validity of the study is maintained. This approach limits the interpretation of our findings to historical ascertainment of asthma and allergy from questionnaire data, and not necessarily to parental atopy.
Our results showed a significant increase in FVC in children who were breastfed for longer than 4 months (table 2, model 1). Including FVC in the explanatory model for FEV1 is comparable to the division of FEV1 by FVC (table 2, model 1). The method of adjustment we used in model 2 has been applied in other studies and was shown to produce consistent results with minimal bias.29 The loss of statistical significance for breastfeeding duration on FEV1 after adjustment for FVC supports the notion that FVC may play a mediating role (breastfeeding → increased lung capacity → increased FEV1). Thus the association of breastfeeding with FVC seems to explain the increase in FEV1. Therefore, we believe that the effect of breastfeeding in our data is because of an increase in lung volume. Nevertheless, even after including FVC in the model, duration of breastfeeding was still associated with PEF, suggesting that breastfeeding may have some protective effect against airflow obstruction.
Unlike Guilbert and colleagues22 we did not find any effect of breastfeeding duration on the FEV1/FVC ratio. This may be due to the fact that an effect of similar strength acted on both FEV1 and FVC in our population. In other words, the primary effect is on lung capacity and secondarily on FEV1. If so, the use of a ratio would nullify the effect of breastfeeding. As the FEV1/FVC ratio was not affected, our findings support an effect of prolonged breastfeeding on increased lung volumes, but no effect of breastfeeding duration on airway obstruction.
The results of previous studies suggest that factors in human breast milk, such as cytokines and chemokines, are responsible for the beneficial effects of breastfeeding on asthma and other allergic disorders.7 8 This view is supported by a recent report by Snijders et al30 who found that longer duration of breastfeeding was associated with a reduced risk for eczema when the mothers were non-allergic and non-asthmatic. They concluded that maternal allergic status was the major driver of this protective effect.30 Similar immune mechanisms may act by remodelling the airways and may explain the protective effect of breastfeeding duration on PEF.
While immunoactive factors are important, the effect of breastfeeding on the respiratory system may be a result of complex and interlinked mechanisms that may be accounted for by several variables. It has been demonstrated that during breastfeeding, for the 75 s prior to milk ejection, there is a negative pressure of up to 98 mm Hg, which is about three times higher than the pressure developed during bottle feeding.31 Sucking exercises during breastfeeding (an average of 8 min) is nearly twice as long as bottle feeding duration (4.4 min). In addition, bottle feeding has a higher rate of swallowing, more frequent interruption of breathing and decreased ventilatory efforts.32-34 Hence mechanical factors related to suckling may explain the differences in lung volume seen in breastfed infants compared with those who were not breastfed. For lung function, it may be that the physical exercise caused by suckling at the breast, about six times daily on average (for more than 4 months), may result in increased elasticity and efficiency of the lung parenchyma, resulting in increased lung capacity and increased airflow in breastfed children compared with bottle-fed children. This interpretation is supported by our finding that FVC (and only indirectly FEV1) was higher in breastfed children.
Hence two explanatory mechanisms may compete. Firstly, prolonged suckling at the breast compared with the bottle may convey a mechanical stimulus that results in improved mechanics of ventilation (due to physical training). Secondly, the presence of protective immunoactive factors in breast milk may reduce allergic susceptibility of the lung tissue. This differentiation is relevant for future efforts to promote better lung growth. Pumping and subsequently bottle-feeding (indirect feeding) may eliminate the protective effects of breastfeeding, thus explaining the negative findings in some studies,16 21 35 especially in countries with minimal maternity leave periods. This mechanical explanation necessitates the collection of data on the method of breast milk administration employed in different studies. In addition, if suckling is essential and the newborn cannot be breastfed, then the design of the feeding bottle is important. For instance, an artificial increase of flow “resistance” from infant feeding bottles may be beneficial. On the other hand, if immune factors are essential, it would be important to investigate which constituents of breast milk provide the most protection.
In conclusion, this paper adds to the evidence supporting the promotion of prolonged breastfeeding for the improvement of lung volume in late childhood. In addition to repeating this analysis in other populations, future studies should assess the biological mechanisms that drive this phenomenon, in order to promote normal lung growth and development.
Acknowledgements
The authors gratefully acknowledge the cooperation of the children and parents who participated in this study, and appreciate the hard work of Mrs Sharon Matthews and the Isle of Wight research team in collecting phenotype data. The authors thank Hans Cheng for use of pyrosequencing equipment and Dennis Shubitowski for technical assistance.
Funding: This study was funded in part by the National Institutes of Health R01 AI061471. The 10-year follow-up of this study was funded by National Asthma Campaign, UK (Grant No 364).
Footnotes
Competing interests: None.
Ethics approval: The local research ethics committee approved the study.
1. Bottcher MF, Jenmalm MC, Bjorksten B, et al. Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res. 2000;47:592–7. [PubMed]
2. Bottcher MF, Jenmalm MC, Garofalo RP, et al. Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res. 2000;47:157–62. [PubMed]
3. Bryan DL, Hawkes JS, Gibson RA. Interleukin-12 in human milk. Pediatr Res. 1999;45:858–9. [PubMed]
4. Buts JP. Bioactive factors in milk. Arch Pediatr. 1998;5:298–306. [PubMed]
5. Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am. 2001;48:69–86. [PubMed]
6. Hanson LA. Human milk and host defence: immediate and long-term effects. Acta Paediatr Suppl. 1999;88:42–6. [PubMed]
7. Hawkes JS, Bryan DL, James MJ, et al. Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res. 1999;46:194–9. [PubMed]
8. Oddy WH, Halonen M, Martinez FD, et al. TGF-beta in human milk is associated with wheeze in infancy. J Allergy Clin Immunol. 2003;112:723–8. [PubMed]
9. Saito S, Yoshida M, Ichijo M, et al. Transforming growth factor-beta (TGF-beta) in human milk. Clin Exp Immunol. 1993;94:220–4. [PubMed]
10. Cushing AH, Samet JM, Lambert WE, et al. Breastfeeding reduces risk of respiratory illness in infants. Am J Epidemiol. 1998;147:863–70. [PubMed]
11. Nafstad P, Jaakkola JJ, Hagen JA, et al. Breastfeeding, maternal smoking and lower respiratory tract infections. Eur Respir J. 1996;9:2623–9. [PubMed]
12. Oddy WH. Breastfeeding protects against illness and infection in infants and children: a review of the evidence. Breastfeed Rev. 2001;9:11–18. [PubMed]
13. Oddy WH, Sly PD, de Klerk NH, et al. Breast feeding and respiratory morbidity in infancy: a birth cohort study. Arch Dis Child. 2003;88:224–8. [PMC free article] [PubMed]
14. Sinha A, Madden J, Ross-Degnan D, et al. Reduced risk of neonatal respiratory infections among breastfed girls but not boys. Pediatrics. 2003;112:e303. [PubMed]
15. Wilson AC, Forsyth JS, Greene SA, et al. Relation of infant diet to childhood health: seven year follow up of cohort of children in Dundee infant feeding study. BMJ. 1998;316:21–5. [PMC free article] [PubMed]
16. Burgess SW, Dakin CJ, O'Callaghan MJ. Breastfeeding does not increase the risk of asthma at 14 years. Pediatrics. 2006;117:e787–92. [PubMed]
17. Burr ML, Limb ES, Maguire MJ, et al. Infant feeding, wheezing, and allergy: a prospective study. Arch Dis Child. 1993;68:724–8. [PMC free article] [PubMed]
18. Chulada PC, Arbes SJ, Jr, Dunson D, et al. Breast-feeding and the prevalence of asthma and wheeze in children: analyses from the Third National Health and Nutrition Examination Survey, 1988–1994. J Allergy Clin Immunol. 2003;111:328–36. [PubMed]
19. Kull I, Almqvist C, Lilja G, et al. Breast-feeding reduces the risk of asthma during the first 4 years of life. J Allergy Clin Immunol. 2004;114:755–60. [PubMed]
20. Oddy WH, Holt PG, Sly PD, et al. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. BMJ. 1999;319:815–19. [PMC free article] [PubMed]
21. Wright AL, Holberg CJ, Taussig LM, et al. Factors influencing the relation of infant feeding to asthma and recurrent wheeze in childhood. Thorax. 2001;56:192–7. [PMC free article] [PubMed]
22. Guilbert TW, Stern DA, Morgan WJ, et al. Effect of breastfeeding on lung function in childhood and modulation by maternal asthma and atopy. Am J Respir Crit Care Med. 2007;176:843–8. [PMC free article] [PubMed]
23. Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 2006;355:1682–9. [PubMed]
24. Kurukulaaratchy RJ, Fenn MH, Waterhouse LM, et al. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy. 2003;33:573–8. [PubMed]
25. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic disorders in infancy. J Allergy Clin Immunol. 1992;90:235–41. [PubMed]
26. Kurukulaaratchy RJ, Fenn M, Twiselton R, et al. The prevalence of asthma and wheezing illnesses amongst 10-year-old schoolchildren. Respir Med. 2002;96:163–9. [PubMed]
27. ATS Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107–36. [PubMed]
28. Sadeghnejad A, Karmaus W, Arshad SH, et al. IL13 gene polymorphisms modify the effect of exposure to tobacco smoke on persistent wheeze and asthma in childhood, a longitudinal study. Respir Res. 2008;9:2. [PMC free article] [PubMed]
29. Schisterman EF, Whitcomb BW, Louis GM, et al. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect. 2005;113:853–7. [PMC free article] [PubMed]
30. Snijders BE, Thijs C, Dagnelie PC, et al. Breast-feeding duration and infant atopic manifestations, by maternal allergic status, in the first 2 years of life (KOALA study). J Pediatr. 2007;151:347–51. 351 e1–2. [PubMed]
31. Mizuno K, Ueda A. Changes in sucking performance from nonnutritive sucking to nutritive sucking during breast- and bottle-feeding. Pediatr Res. 2006;59:728–31. [PubMed]
32. Miller MJ, DiFiore JM. A comparison of swallowing during apnea and periodic breathing in premature infants. Pediatr Res. 1995;37:796–9. [PubMed]
33. Goldfield EC, Richardson MJ, Lee KG, et al. Coordination of sucking, swallowing, and breathing and oxygen saturation during early infant breast-feeding and bottle-feeding. Pediatr Res. 2006;60:450–5. [PubMed]
34. Koenig JS, Davies AM, Thach BT. Coordination of breathing, sucking, and swallowing during bottle feedings in human infants. J Appl Physiol. 1990;69:1623–9. [PubMed]
35. Sears MR, Greene JM, Willan AR, et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet. 2002;360:901–7. [PubMed]